You are here:
06 November 2014
Immunisation workers in India prepare for 5-in-1 pentavalent vaccine
As India prepares to protect children against more diseases with the 5-in-1 vaccine, we travel to Rajasthan and Uttar Pradesh to hear about the preparations being made.
31 October 2014
New animation tells Gavi, the Vaccine Alliance story
The story of what Gavi does and how it works is told in this new animation.
26 September 2014
Reaching every child in Cameroon
Short film highlighting the challenges and rewards of delivering vaccines to a remote coastal region in Cameroon.This video was produced for the Global Citizen's Festival, held in in New York's Central Park in September 2014.
02 September 2014
South Sudan overcomes great obstacles to protect children
Despite conflict, the South Sudanese government brings in five-in-one pentavalent vaccine with Gavi support.
30 July 2014
73 countries, five diseases, one amazing vaccine
How the 5-in-1 pentavalent vaccine is now protecting children in all of the world's poorest countries
27 November 2013
GAVI supported rotavirus vaccines introduced in Zambia
Following a successful pilot program delivering rotavirus vaccines as part of an integrated approach to diarrhoea prevention and control, in November 2013, Zambia rolled out GAVI-supported rotavirus vaccines nationwide. Rotavirus, the most common cause of severe and fatal diarrhoea in young children worldwide, takes the lives of over 3,600 Zambian children under five each year and accounts for approximately 40 percent of all under-five diarrhoeal deaths and hospitalisations. Zambia is the 18th GAVI-eligible country to introduce rotavirus vaccines in its national immunisation program. (credit VITAC-PATH)
28 October 2014
Pentavalent: 1 vaccine, 5 diseases, 73 countries
The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but only 50% of the children are being reached. Learn more about the pentavalent success story – and the challenges that remain.
27 October 2014
Immunisation progress in Asia-Pacific
Presentation on immunisation in Asia-Pacific, including support for pentavalent, pneumococcal, measles, rubella, HPV, Japanese encephalitis, hepatitis B and inactivated polio vaccines, the growing number of manufacturers of Gavi-funded vaccines based in the region, and the increasing co-financing contributions by countries. Despite this progress, challenges remain: almost half of the world’s under-immunised children are in Gavi-supported countries in Asia-Pacific.
01 October 2014
Economic benefits of vaccines
This short presentation sets out the growing body of evidence to show the economic impact of vaccination through direct and indirect cost savings, as well as contributions to the broader economy.
28 November 2014
Increasing support for immunisation in Francophone countries
Current information and projections for increased support for Francophone countries by Gavi during the period 2016 - 2020.
Download high resolution PDF version
12 November 2014
Pneumococcal disease: the biggest vaccine-preventable cause of death in children under five
Pneumonia kills as many as 1 million children under five and pneumococcal disease is the leading cause of pneumonia. Countries introducing pneumococcal vaccines with Gavi support could prevent 500,000 early deaths by 2015.
04 November 2014
Nearly one third of all unimmunised children live in India
India currently has 6.8 million of the 18.5 million under-immunised children in Gavi-supported countries. As of 2014, India and the Vaccine Alliance have joined forces for an unprecedented national scale-up of the 5-in-1 pentavalent vaccine.
GAVI broadcast quality video:
The latest GAVI B-roll is available for interested broadcasters to review at: www.gavivideo.org
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2014
modal window here